ARCHIVES

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

Text of Peer Review Of Medenica’s Treatment Of Breast Cancer Patient

April 30, 1993

Chemoprevention Clinical Trials To starts In 1982 If Greenwald, DRCCA Board Can Move Fast Enough

August 28, 1981

NCI Gets Concept Approval for New Communications Network

May 27, 1988

NCI 1980s Challenge: Matching Schientific Priorities With Resources, DeVita Says At Swearing-In

August 15, 1980

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

Chart of Core Grants

October 18, 1991